SCRA Technology Ventures this week accepted Greenville-based Purilogics into its SC Launch Program.
Purilogics provides advanced separation technologies for the biopharmaceutical industry. The company develops products that enable biopharmaceutical manufacturers to increase production capacity and simultaneously lower the cost of biologics, which are a class of drugs in high demand for treating such severe and chronic conditions as cancer and cardiovascular and rheumatoid diseases.
Companies accepted into the SC Launch economic development program receive mentoring and other support services. These companies may be eligible to receive matching funding or larger investment funds.
